Kristinsson Valur Helgi
Laeknabladid. 2005 Sep;91(9):657-60.
To investigate the efficiency of warfarin management in Húsavík Health Care Center.
All patients receiving warfarin treatment managed in Húsavík in the years 2001 and 2003 were included in the study. Main outcome measures were the percentage time within INR target range (Rosendaal) and whether the management was deemed satisfactory or unsatisfactory (defined as <3 measurements per year).
In 2001 there were 34 patients receiving warfarin treatment in Húsavík but 57 in 2003. Median age was 71.5 and 76 years, 65% and 67% were males, indication for treatment was atrial fibrillation in 53% and 73% and INR target range was 2.0-3.0 in 74% and 86% respectively. The management was deemed unsatisfactory in 38.2% in 2001 but 10.5% in 2003 (27.7% absolute reduction, p=0.0017). Percentage time spent within target range was 61.2% and 63.1% respectively.
These findings suggest that the quality of anticoagulant control in Húsavík is adequate and fully comparable with that shown in previous studies from our neighbouring countries.
调查胡萨维克医疗中心华法林管理的效率。
纳入2001年和2003年在胡萨维克接受华法林治疗的所有患者。主要观察指标为国际标准化比值(INR)在目标范围内的时间百分比(罗森达尔法)以及管理是否被认为满意或不满意(定义为每年测量次数<3次)。
2001年有34例患者在胡萨维克接受华法林治疗,2003年有57例。中位年龄分别为71.5岁和76岁,男性分别占65%和67%,治疗指征为房颤的分别占53%和73%,INR目标范围分别为2.0 - 3.0的占74%和86%。2001年管理被认为不满意的占38.2%,2003年为10.5%(绝对降低27.7%,p = 0.0017)。在目标范围内花费的时间百分比分别为61.2%和63.1%。
这些结果表明,胡萨维克抗凝控制的质量是足够的,并且与我们邻国以前的研究结果完全可比。